Logo image
Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses
Journal article   Open access   Peer reviewed

Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses

Jinhong Chang, Lijuan Wang, Dongling Ma, Xiaowang Qu, Haitao Guo, Xiaodong Xu, Peter M Mason, Nigel Bourne, Robert Moriarty, Baohua Gu, …
Antimicrobial agents and chemotherapy, v 53(4), pp 1501-1508
Apr 2009
PMID: 19223639
url
https://doi.org/10.1128/aac.01457-08View
Published, Version of Record (VoR)Open Access (License Unspecified) Open
url
https://doi.org/10.1128/AAC.01457-08View
Published, Version of Record (VoR) Open

Abstract

1-Deoxynojirimycin Antiviral Agents Flavivirus Glycoside Hydrolase Inhibitors Imino Sugars
Imino sugars, such as N-butyl-deoxynojirimycin and N-nonyl-deoxynojirimycin (NNDNJ), are glucose analogues that selectively inhibit cellular α-glucosidase I and II in the endoplasmic reticulum and exhibit antiviral activities against many types of enveloped viruses. Although these molecules have broad-spectrum antiviral activity, their development has been limited by a lack of efficacy and/or selectivity. We have previously reported that a DNJ derivative with a hydroxylated cyclohexyl side chain, called OSL-95II, has an antiviral efficacy similar to that of NNDNJ but significantly less toxicity. Building upon this observation, a family of imino sugar derivatives containing an oxygenated side chain and terminally restricted ring structures were synthesized and shown to have low cytotoxicity and superior antiviral activity against members of the Flaviviridae family, including bovine viral diarrhea virus, dengue virus (DENV), and West Nile virus. Of particular interest is that several of these novel imino sugar derivatives, such as PBDNJ0801, PBDNJ0803, and PBDNJ0804, potently inhibit DENV infection in vitro, with 90% effective concentration values at submicromolar concentrations and selectivity indices greater than 800. Therefore, these compounds represent the best in their class and may offer realistic candidates for the development of antiviral therapeutics against human DENV infections.

Metrics

2 Record Views
75 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Microbiology
Pharmacology & Pharmacy
Logo image